🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Shares

BioRestorative Therapies Inc (BRTX)

NASDAQ
Currency in USD
1.460
-0.010(-0.68%)
Closed
After Hours
1.450-0.010(-0.685%)
BRTX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
1.4001.500
52 wk Range
1.0303.670
Key Statistics
Edit
Prev. Close
1.47
Open
1.46
Day's Range
1.4-1.5
52 wk Range
1.03-3.67
Volume
27.5K
Average Volume (3m)
50.49K
1-Year Change
-20.65%
Book Value / Share
1.44
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BRTX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
13.000
Upside
+790.411%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

BioRestorative Therapies Inc Company Profile

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs relate to the treatment of disc/spine disease and metabolic disorders. Its products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient’s bone marrow, as well as used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure; and ThermoStem, a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. The company also provides investigational curved needle device to deliver cells and/or other therapeutic products or material to the spine and discs, and other parts of the body. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. is based in Melville, New York.

Compare BRTX to Peers and Sector

Metrics to compare
BRTX
Peers
Sector
Relationship
P/E Ratio
−1.0x−1.3x−0.6x
PEG Ratio
−0.050.010.00
Price/Book
1.0x1.0x2.6x
Price / LTM Sales
26.8x25.0x3.2x
Upside (Analyst Target)
-328.2%40.6%
Fair Value Upside
Unlock16.4%7.1%Unlock

Analysts' Recommendations

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 13.000

(+790.41% Upside)

People Also Watch

0.4101
IDAI
-16.23%
1.300
UCL
0.00%
0.5210
NKGN
+6.07%
6.7900
ENSC
-0.88%
2.650
TAIT
+0.38%

FAQ

What Is the BioRestorative Therapies (BRTX) Stock Price Today?

The BioRestorative Therapies stock price today is 1.46

What Stock Exchange Does BioRestorative Therapies Trade On?

BioRestorative Therapies is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for BioRestorative Therapies?

The stock symbol for BioRestorative Therapies is "BRTX."

What Is the BioRestorative Therapies Market Cap?

As of today, BioRestorative Therapies market cap is 10.31M.

What is BioRestorative Therapies Earnings Per Share?

The BioRestorative Therapies EPS is -1.40.

What Is the Next BioRestorative Therapies Earnings Date?

BioRestorative Therapies will release its next earnings report on 25 Feb 2025.

From a Technical Analysis Perspective, Is BRTX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.